Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA1)

PHASE3CompletedINTERVENTIONAL
Enrollment

706

Participants

Timeline

Start Date

November 23, 2020

Primary Completion Date

April 19, 2022

Study Completion Date

April 19, 2022

Conditions
Alopecia Areata
Interventions
DRUG

CTP-543 matching placebo

Administered as tablets.

DRUG

CTP-543

Administered as tablets.

DRUG

CTP-543

Administered as tablets.

Trial Locations (72)

8036

Hospital Clínico Y Provincial de Barcelona, Barcelona

10075

Sadick Research Group, New York

13385

Hôpital La Timone-Dermatologie, Marseille

15241

PEAK Research, Upper Saint Clair

17000

Hôpital Saint-Louis - Gh de La Rochelle, La Rochelle

19104

University of Pennsylvania, Philadelphia

19462

Dermatology Associates Of Plymouth Meeting, Plymouth Meeting

23233

West End Dermatology Associates, Richmond

27157

Wake Forest University Health Sciences, Department of Dermatology, Winston-Salem

28034

H. U. Ramón y Cajal, Madrid

28277

Darst Dermatology, Charlotte

Dermatology Specialists of Charlotte, Charlotte

29407

Clinical Research Center of the Carolinas, Charleston

29644

Palmetto Clinical Trial Services, Fountain Inn

33075

Hôpital Saint-André - Chu de Bordeaux, Bordeaux

33172

Lenus Research & Medical Group, LLC, Sweetwater

33607

Clinical Research Trials of Florida, Inc., Tampa

33624

Forward Clinical Trials Inc., Tampa

35205

Total Skin and Beauty Dermatology Center, Birmingham

40241

DS Research, Louisville

42301

Qualmedica Research LLC, Owensboro

43209

Bexley Dermatology Research, Bexley

44093

Hôpital Hotel Dieu - Chu de Nantes, Nantes

46168

The Indiana Clinical Trials Center, PC, Plainfield

46250

Dawes Fretzin Clinical Research Group, LLC, Indianapolis

47150

DS Research, New Albany

48346

Clarkston Skin Research, Clarkston

53144

Clinical Investigation Specialists, Inc., Kenosha

55432

Minnesota Clinical Study Center, Fridley

55455

University of Minnesota Department of Dermatology, Minneapolis

60611

Denova Research, Chicago

Northwestern Memorial Hospital, Department of Dermatology, Chicago

74136

Vital Prospects Clinical Research Institute, P.C., Tulsa

75010

Hôpital Saint Louis, Centre de Santé Sabouraud, Paris

75230

Dermatology Treatment and Research Center, Dallas

77056

Austin Institute for Clinical Research, Inc., Houston

77401

Bellaire Dermatology Associates, Bellaire

78229

Dermatology Clinical Research Center of San Antonio, San Antonio

78660

Austin Institute for Clinical Research, Inc., Pflugerville

80111

Colorado Center for Dermatology and Skin Surgery, Centennial

80210

Colorado Medical Research Center, Denver

91324

Quest Dermatology Research, Northridge

92024

California Dermatology & Clinical Research Institute, Encinitas

92697

UC Irvine Dermatology Clinical Research Center, Irvine

93301

Kern Research, Inc., Bakersfield

94118

Kaiser Permanente, San Francisco

94611

Kaiser Permanente, Oakland

95823

Kaiser Permanente South Sacramento, Sacramento

97210

Northwest Dermatology Institute, Portland

06519

Yale University, Church Street Research Unit, New Haven

02114

Massachusetts General Hospital - Clinic, Boston

02115

Brigham and Women's Hospital, Boston

07601

Skin Laser and Surgery Specialists of NJ, Hackensack

02903

Rhode Island Hospital, Providence

T1Y 0B4

Dermatology Research Institute, Calgary

T2G 1B1

Kirk Barber Research, Calgary

V3V 0C6

Enverus Medical Research, Surrey

R3M 3Z4

Wiseman Dermatology Research Inc., Winnipeg

L4M 7G1

SimcoDerm Medical and Surgical Dermatology Center, Barrie

N1L 0B7

Guelph Dermatology Research, Guelph

N6H 5L5

Dr Wei Jing Loo Medicine Professional Corporation, London

L3P 1X3

Lynderm Research Inc., Markham

L3Y 5G8

Dr. S. K. Siddha Medicine Professional Corporation, Newmarket

L6J 7W5

The Centre for Clinical Trials, Oakville

K1H 7X3

JRB Research Inc., Ottawa

M4W 2N4

Research Toronto, Toronto

N2J 1C4

K. Papp Clinical Research Inc., Waterloo

H2X 2V1

Innovaderm Research Inc. - Clinic, Montreal

40-748

Vita Longa Sp.Zo.O, Katowice

31-147

SGD S.C., Krakow

00-144

My Clinic, Warsaw

02-962

Royalderm Agnieszka Nawrocka, Warsaw

Sponsors
All Listed Sponsors
lead

Concert Pharmaceuticals

INDUSTRY

NCT04518995 - Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA1) | Biotech Hunter | Biotech Hunter